CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines Monthey, Switzerland & Freiburg, Germany – Today, CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant […]
LEIDEN, The Netherlands — MIMETAS, a global leader in Organ-on-a-Chip models and technology, announces today that it has expanded its license to the HUB Organoid Technology to include all organs. The license covers organoid technology developed by Professor Hans Clevers, a pioneer in adult stem cells. “This is a crucial addition to our Organ-on-a-Chip disease models,” says Jos […]
SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an automation and instrumentation company focused on cell therapy manufacturing, today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer. A veteran of the cell and gene therapy industry, Dr. Eaker will be responsible for driving Xcellbio’s instrument and software development strategy and the commercial delivery […]
Propath UK is the first contract research organization in Europe to offer COMET™ services to biopharmaceutical researchers. LAUSANNE, Switzerland and HEREFORD, United Kingdom – Lunaphore, a Swiss life sciences company developing technologies to enable spatial biology in every laboratory, today announced that it has deployed its COMET™ PA instrument at Propath UK, one of Europe’s leading contract research organizations (CRO). […]
Apollo, powered by RedShift BioAnalytics’ proprietary MMS technology, incorporates major advances over first-generation AQS³pro to support rapidly growing market demand. Burlington, MA – RedShift BioAnalytics (RedShiftBioⓇ) announces the launch of Apollo, the company’s latest system using ground-breaking MMS technology. Apollo provides ultra-sensitive, ultra-precise measurements of the structure of biomolecules through a novel technology called Microfluidic […]
Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the inaugural members of the BD Scientific Advisory Board (SAB), which is comprised of top external medical key opinion […]
Thermo Fisher Scientific’s Invitrogen TrueTag Donor DNA Kits* provide a straightforward toolset to simplify and accelerate cell line engineering with CRISPR-Cas9 or TALEN technology. With the kits, researchers can enrich tagged cells to obtain up to 100% of edited cells. This enables them to skip the time-consuming clonal isolation step and save up to four […]
AMSBIO announce the launch of its StemFit Purotein® range of high purity, high activity recombinant proteins for cell therapy applications. Continued expansion of cell therapy applications across healthcare and the life sciences is driving a rapidly increasing need for clinically applicable ancillary materials. A key requirement is for recombinant proteins, such as growth factors and […]
Mikael Engblom will take the position as interim CFO for BICO (publ) from 29 April 2022 until a new permanent CFO is in place. Engblom will be part of Group management during this period. BICO announced on April 26, 2022 that the former CFO has left the company and that a recruitment process for a […]
Industry Seasoned Executive Joins Cytek FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Todd Garland as Chief Commercial Officer, Cytek Biosciences, Inc. Garland’s appointment is effective immediately, reporting directly to Dr. Wenbin Jiang, Chairman and CEO of Cytek Biosciences. “I have long admired Cytek’s […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
